REFERENCES
- Victorian Medical Postgraduate Foundation. Psychotropic drug guidelines. 3rd ed. Victorian Medical Postgraduate Foundation, Melbourne 1995
- Furrows D C. Cardiotoxicity associated with use of intravenous haloperidol [letter]. Australian and New Zealand Journal of Psychiatry 1999; 33: 284
- Hunt N, Stern T. The association between intravenous haloperidol and Torsades de Pointes. Psychosomatics 1995; 36: 541–549
- Sharma N D, Rosman H S, Padhi D, Tisdale J E. Torsades de Pointes associated with intravenous haloperidol in critically ill patients. American Journal of Cardiology 1998; 81: 238–240
- Lawrence K R, Nasraway S A. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature. Pharmacotherapy 1997; 17: 531–537